Envision Pharma Group

Want to learn more about measuring the impact of #MedicalAffairs? In our latest collaboration with PM360 Magazine, Angus Bromley, Senior Vice President of Strategic Consulting and a medical strategy expert, shares frameworks to help teams align on this critical – but often misunderstood – discipline.   Discover how medical leaders are driving better cross-collaboration, faster decision-making, and ultimately improved patient outcomes. Read the full article here 👇https://lnkd.in/gKfUTkgD #Biotech #MedicalAffairs #MedicalInsights #EnvisionPharmaGroup #TwoLabs 

How can pharma companies turn mountains of data into actionable insights in record time? 📊 We recently partnered with a leading global pharmaceutical client to streamline their insights journey, enabling them to analyze over 100,000 data records from more than 50 countries in just 2 weeks – down from 5 months! Through the power of OKRA.ai and our dedicated team, we uncovered critical insights that had previously gone unnoticed. This transformation not only enhanced their understanding of emerging educational gaps but also reshaped their strategies for side-effect management. Download our case study today to see how we can empower your organization to harness data effectively and make impactful data-driven decisions. 👇 https://lnkd.in/eci9R6an #MedicalAffairs #MedicalData #HealthcareInnovation

At Envision Pharma Group, we partner across the entire product lifecycle, helping biopharma companies tackle complex challenges—from early commercial strategy to ensuring market access. At this year’s #MeetingontheMesa, Kyle Felmet, VP of Specialty Commercialization, led a panel that explored these critical aspects of cell and gene therapy commercialization. The insights shared underscore how overcoming barriers like reimbursement ensures that life-changing therapies reach patients. #CGT #PatientAccess #LifeSciences

Exciting day ahead at Employer Engagement, University of Cambridge Careers Service's Engineering & Tech Careers Fair! Anna Piecha, Alessio Caciagli, and Rachel Musgrave from OKRA.ai, part of Envision Pharma Group, are ready to meet bright minds and future innovators. They’re eager to welcome new talent, share insights on AI, engineering, and technology, and explore how we can shape the future together. #Engineering #TechFair #AIInnovation #FutureLeaders 

Anti-obesity medications are rapidly becoming the next pharma megatrend, with glucagon-like peptide-1 (GLP-1) receptor agonists at the forefront. Originally developed for diabetes, these medications are now emerging as a leading weight-loss solution, with sales projected to exceed $125 billion by 2033.   This shift highlights the evolving patient demand but also presents unique challenges. We’re excited to share our insights on the efficacy, safety, patient outcomes, and reimbursement trends of GLP-1 receptor agonists, as well as their future potential in weight management at #ISPOREU. Suki Kandola and Arabella Stanley are looking forward to connecting with peers and discussing this transformative innovation in obesity treatment. #ISPOR2024 #GLP1 #ObesityManagement #HealthcareInnovation #Value #Access

🔍Overcoming AI Anxiety in Medical Affairs: Strategies For Successful Adoption The pharmaceutical industry is rapidly integrating artificial intelligence (AI) into many facets of medical affairs. From improving drug development to refining patient engagement strategies, the potential for AI is vast. Yet, despite these advancements, some challenges still create “AI anxiety” within medical affairs teams. In her latest article published by the International Pharmaceutical Industry Journal, our very own Alice Di Giulio, AI Frontier PR Lead at Envision Pharma Group, dives deep into these concerns. She explores common misconceptions, ethical dilemmas, and the growing need for transparency while outlining practical strategies for overcoming barriers to AI adoption. Key takeaways include: ·      Demonstrating the tangible benefits and return on investment of AI initiatives ·      Deploying and scaling AI with robust infrastructure ·      Building trust through transparency and explainability of AI models ·      Addressing biases and ethical considerations in data usage ·      Aligning AI technologies with existing workflows for seamless integration By embracing these strategies, the medical affairs community can unlock the true potential of AI while alleviating concerns. Read the full article to discover how we’re tackling these challenges head-on: https://lnkd.in/emfFHJX6 #AIinPharma #MedicalAffairs #AIAdoption #DigitalTransformation #LifeSciences #Innovation #IPI

In our latest article with PM360 Magazine, Rebecca Goldstein, PhD, CMPP, Senior Principal of Strategic Consulting, explores the unique challenges pharmaceutical companies face in this evolving field. She emphasizes that successful oncology commercialization hinges on understanding how innovations address patient needs at launch. The article also highlights the complexities posed by hyper-segmented oncology markets, driven by scientific advancements and regulatory changes. Learn how early, informed decision-making can drive oncology innovation and improve patient outcomes by reading the full article here. 👇 https://lnkd.in/ePr98iVP #Oncology #CommercialStrategy #Commercialization 

Last chance to register for the EnvisionOne Insights webinar! Don’t miss this opportunity to discover how our newest solution enables smooth and efficient data movement across Envision Technology Solutions and multiple data sources. Delivering actionable insights to support clinical and commercial team success will become your superpower. https://lnkd.in/g5uwpVm5

We recently shared Suki Kandola’s post, "The hidden threat to systematic literature reviews (SLRs)." If you would like to discuss Envision’s expertise in SLRs, please reach out to Suki directly, or contact Value@envisionpharma.com to arrange a meeting at #ISPOREU. #SystematicReviews #ValueandAccess #ISPOR 

Just a few more days until the EnvisionOne Insights webinar! Register today to discover how this new solution enables smooth and efficient data movement across Envision Technology Solutions and multiple data sources. Delivering actionable insights to support clinical and commercial team success will become your superpower.   Register now to gain insights! https://lnkd.in/g5uwpVm5